Tag: #clinicaltrial

Articles related to clinicaltrial

health

Once‑Weekly Oral HIV Pill Maintains Viral Suppression Through 48 Weeks in Phase 3 Trial

Phase 3 Lancet study: a once‑weekly islatravir‑lenacapavir single‑tablet regimen maintained HIV‑1 viral suppression through 48 weeks, matching daily therapy.

#hiv, #islatravir, #lenacapavir, #antiretroviral, #clinicaltrial